The German government has started discussions about its new Pharma Strategy1, driven by the growing complexity and multi-enterprise dependencies associated with life sciences and healthcare supply chains. The proposed reforms aim to, in part, incentivise manufacturing in the EU, diversifying supply chains, and promoting innovation.
PwC reports "30-40% downtime reduction in pharma plants through digitisation."2 Companies have a huge opportunity to gain competitive advantage in the German market by digitalising their transactions with contract manufacturers and across other supply chain relationships.
Join PwC and TraceLink for an exclusive in-person discussion with life sciences leaders dedicated to exploring the future of life sciences and healthcare supply chain orchestration and digitalisation in Germany and across the EU.
| 15:00 – 15:30 | Registration and Welcome Coffee |
| 15:30 – 15:45 | Opening (Joanna Uebbing, TraceLink) Importance of supply chain orchestration and digitalization for the Pharma and Life Science Supply Chain in Germany |
| 15:45 - 16:05 | Keynote (Thomas Schnur, PwC) “Reinventing supply chains 2030 - Towards an adaptable, sustainable and cognitive ecosystem. The PwC Supply Chain Compass to navigate trends and opportunities applied to Pharma” |
| 16:05 - 16:20 | Shaping the future - strategic outlook (Joanna Uebbing, TraceLink) “A Practical Path to Unlock Real-Time Intelligence in External Manufacturing Networks for Life Sciences Companies and CMOs” |
| 16:20 - 16:30 | Coffee Break and Networking |
| 16:30 - 17:30 |
Interactive discussion panel with the audience
"Digitalisation and Innovation in the Supply Chain: End-to-End Visibility and Real-Time Data Exchange” Panelist:
|
| 17:30 - 18:00 | Summary |
| 18:00 | Aperitif & Canapés |
1 "Strategiepapier 4.0: Verbesserung der Rahmenbedingungen für den Pharmabereich in Deutschland – Handlungskonzepte für den Forschungs- und Produktionsstandort"
2 "Digitization in pharma & Gaining an edge in operations", PwC
